AstraZeneca profits soar on cancer drugs, Alexion buy

British drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.

source https://medicalxpress.com/news/2023-02-astrazeneca-profits-soar-cancer-drugs.html